Skip to Content
Merck
  • Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.

eLife (2018-07-14)
Erin G Conlon, Delphine Fagegaltier, Phaedra Agius, Julia Davis-Porada, James Gregory, Isabel Hubbard, Kristy Kang, Duyang Kim, Hemali Phatnani, Justin Kwan, Dhruv Sareen, James R Broach, Zachary Simmons, Ximena Arcila-Londono, Edward B Lee, Vivianna M Van Deerlin, Neil A Shneider, Ernest Fraenkel, Lyle W Ostrow, Frank Baas, Noah Zaitlen, James D Berry, Andrea Malaspina, Pietro Fratta, Gregory A Cox, Leslie M Thompson, Steve Finkbeiner, Efthimios Dardiotis, Timothy M Miller, Siddharthan Chandran, Suvankar Pal, Eran Hornstein, Daniel J MacGowan, Terry Heiman-Patterson, Molly G Hammell, Nikolaos A Patsopoulos, Joshua Dubnau, Avindra Nath, Hemali Phatnani, Neil A Shneider, James L Manley
ABSTRACT

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent two ends of a disease spectrum with shared clinical, genetic and pathological features. These include near ubiquitous pathological inclusions of the RNA-binding protein (RBP) TDP-43, and often the presence of a GGGGCC expansion in the C9ORF72 (C9) gene. Previously, we reported that the sequestration of hnRNP H altered the splicing of target transcripts in C9ALS patients (Conlon et al., 2016). Here, we show that this signature also occurs in half of 50 postmortem sporadic, non-C9 ALS/FTD brains. Furthermore, and equally surprisingly, these 'like-C9' brains also contained correspondingly high amounts of insoluble TDP-43, as well as several other disease-related RBPs, and this correlates with widespread global splicing defects. Finally, we show that the like-C9 sporadic patients, like actual C9ALS patients, were much more likely to have developed FTD. We propose that these unexpected links between C9 and sporadic ALS/FTD define a common mechanism in this disease spectrum.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-GAPDH antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
Anti-U2AF65 antibody, Mouse monoclonal, clone MC3, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Actin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-SMN antibody, Mouse monoclonal, clone 2B1, purified from hybridoma cell culture